SCHEMBL9954518

SCHEMBL9954518

CCC(C)CC(C)(O)CC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7764507 0.82 TSHR (0.31) TSHR
SCHEMBL14499767 0.82 TSHR (0.31) TSHR
SCHEMBL5907194 0.82 TSHR (0.40) TSHR
SCHEMBL26105237 0.80 TSHR (0.44) TSHR
SCHEMBL4882185 0.80 TSHR (0.31) TSHR
SCHEMBL8605479 0.78 ALDH1A1 (0.34) TSHR
SCHEMBL3101156 0.78
SCHEMBL11890303 0.78
SCHEMBL31425554 0.78
SCHEMBL543718 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312944-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2023-10-05 US claimed
EP-4200365-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2023-06-28 EP claimed
CN-115867614-A UV-curable coating with high refractive index 巴斯夫欧洲公司 2023-03-28 CN claimed
US-20220389245-A1 METAL OXIDE NANOPARTICLES BASF SE (DE) 2022-12-08 US claimed
EP-4031496-A1 METAL OXIDE NANOPARTICLES BASF SE (DE) 2022-07-27 EP claimed
CN-114401927-A Metal oxide nanoparticles 巴斯夫欧洲公司 2022-04-26 CN claimed
WO-2022038161-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2022-02-24 WO claimed
WO-2021052907-A1 METAL OXIDE NANOPARTICLES BASF SE (DE) 2021-03-25 WO claimed
US-20250230374-A1 DUAL-USE COOLANT AND LUBRICANT CUMMINS INC. (US) 2025-07-17 US disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
EP-4422902-A1 DUAL-USE COOLANT AND LUBRICANT Cummins, Inc. (US) 2024-09-04 EP disclosed
CN-118139756-A Dual-purpose coolant and lubricant 康明斯公司 2024-06-04 CN disclosed
CN-118076767-A Method and formulation for producing an optical metal oxide layer 默克专利有限公司 2024-05-24 CN disclosed
CN-117990917-A Exosome protein marker for silicosis and application thereof 杭州医学院 2024-05-07 CN disclosed
EP-2655511-A1 THERMOPLASTIC ELASTOMER COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF BASF SE (DE) 2013-10-30 EP disclosed
US-20120238677-A1 Benzofuranone derivatives and application of the same CHITEC TECHNOLOGY CO., LTD. (TW) 2012-09-20 US disclosed
EP-2500341-A1 Benzofuranone derivatives and application of the same Chitec Technology Co., Ltd. (TW) 2012-09-19 EP disclosed
WO-2012084914-A1 THERMOPLASTIC ELASTOMER COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF BASF SE (DE) 2012-06-28 WO disclosed
US-4287080-A Detergent compositions which contain certain tertiary alcohols THE PROCTER & GAMBLE COMPANY (US) 1981-09-01 US disclosed
US-4111917-A POLYURETHANES W. R. GRACE & CO. (US) 1978-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238677-A1 Benzofuranone derivatives and application of the same HSF1, NFE2L2, SQOR TSHR 4782/4885
US-20250230374-A1 DUAL-USE COOLANT AND LUBRICANT ADH1A, ADH1C, MUC1 TSHR 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.